Valion Bio (VBIO) Share-based Compensation (2021 - 2026)
Valion Bio (VBIO) recorded Share-based Compensation of $149,000 in Q4 2025, up 136.5% from $63,000 a year earlier and up 7.2% from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Share-based Compensation (2021 - 2026) Analysis & Trends
For FY2025, Valion Bio reported Share-based Compensation of $564,000, up 146.3% from FY2024.
- Annual Share-based Compensation has a four-year compound annual growth rate of 19.1% (FY2021 to FY2025).
- Across earlier years, Share-based Compensation came in at $229,000 in FY2024 (-15.5%), $271,000 in FY2023 (-31.9%), $398,000 in FY2022 (+42.1%) and $280,000 in FY2021.
- The Q4 2025 figure is the highest quarterly Share-based Compensation since Q4 2021.
- On a year-over-year basis, Share-based Compensation has increased for six consecutive quarters, with growth averaging 48.6% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 510.0% in Q1 2022, against a decline of 57.5% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $139,000 (Q3 2025), $90,000 (Q2 2025) and $100,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Valion Bio | 130,630.24 | -19.31 Mn | - | 133,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 133,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 54,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 48,000.00 |
| Jun 30, 2023 | 81,000.00 |
| Mar 31, 2023 | 84,000.00 |
| Dec 31, 2022 | 112,000.00 |
| Sep 30, 2022 | 113,000.00 |
| Jun 30, 2022 | 112,000.00 |
| Mar 31, 2022 | 61,000.00 |
| Dec 31, 2021 | 239,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 8,000.00 |
API Access
Valion Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();